Abdominal Arterial Calcification Score‐Association With Patient Survival Post Kidney Transplant
ABSTRACT Background Abdominal arterial calcification (AAC) is a common comorbidity in patients with end‐stage kidney disease (ESKD) and a predictor of cardiovascular events post‐kidney transplant. However, prior studies lacked a standardized approach to evaluate AAC and its impact on post‐transplant outcomes. This study aimed to correlate AAC score values with post‐kidney transplant outcomes using a modified scoring system traditionally applied to coronary artery calcification. Methods This retrospective study included 14 339 adult patients listed for kidney transplant between 2002 and 2023 at three transplant centers. Among them, 3683 patients met the criteria of undergoing a kidney transplant and an abdominal computed tomography (CT) scan pre‐transplant. We modified the coronary calcium score software by adjusting intake data points to quantify calcification in the abdominal aorta, common iliac, external iliac, and internal iliac arteries. Outcomes focused on post‐transplant mortality. Results In 3683 kidney transplant recipients, higher AAC scores were significantly associated with increased mortality. Each 1000‐unit increase in AAC score elevated hazard ratios (HRs) across arterial regions, including 1.116 for the aorta and 1.389 for the internal iliac (all p < 0.001). Adjusted analyses confirmed AAC as an independent risk factor for mortality. Kaplan–Meier curves demonstrated lower survival with increasing AAC quartiles. Conclusions AAC, measured by a standardized score, is a significant mortality risk factor in kidney transplant recipients. Integrating AAC scores into pre‐transplant evaluations could enhance risk stratification and improve outcomes. Prospective studies are needed to validate these findings and explore interventions to reduce AAC and improve survival.
Authors
- Sami Alasfar (ORCID: https://orcid.org/0000-0001-7154-0889)
- Carrie A. Schinstock (ORCID: https://orcid.org/0000-0002-3274-3277)
- Emily C. Craver (ORCID: https://orcid.org/0000-0003-0334-9606)
- Ali Hassoun
- Lauren F. Alexander (ORCID: https://orcid.org/0000-0001-5454-1505)
- Mark D. Stegall (ORCID: https://orcid.org/0000-0002-1392-0792)
- Mohamed Hussam Hallak
- Tambi Jarmi (ORCID: https://orcid.org/0000-0002-9973-0470)
- Tareq Hanouneh
- David M. Sella
- Walid Haddad
- R Ghanem
- Amro Idilbi (ORCID: https://orcid.org/0009-0006-1721-2415)
- Tala Nasrini
Institutions
- Mayo Clinic (US)
- Koç University (TR)
- University of Florida Health (US)
- Jacksonville College (US)
- WinnMed (US)
- Quantitative BioSciences (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic Hospital (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1111/ctr.70387
- Primary Topic
- Renal and Vascular Pathologies
- Type
- article
- Field-Weighted Citation Impact
- 0.00